why choose us

First received: September 22, 2023

Clinical Trial: Safety and Efficacy of OBX-115 in Advanced/Metastatic Melanoma Resistant to Immune Checkpoint Inhibitors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Tumor Skin

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2, Open-Label Study to Investigate the Safety and Efficacy of Membrane Bound IL15 Expressing Tumor-Infiltrating Lymphocytes (OBX-115) In Participants With Unresectable or Metastatic Mel

Brief Summary: This is a study to investigate the safety and efficacy of an investigational regimen, OBX-115, in adult participants with advanced/metastatic melanoma.

Read more